1. Discontinuation of dolutegravir, elvitegravir/cobicistat and raltegravir because of toxicity in a prospective cohort2. Issue 3 (27th January 2019) Authors: Llibre, JM; Montoliu, A; Miró, JM; Domingo, P; Riera, M; Tiraboschi, J; Curran, A; Homar, F; Ambrosioni, J; Abdulghani, N; Force, L; Peraire, J; Casabona, J Other Names: Vilaró Joaquim investigator.; Masabeu Angels investigator.; Orti Amat J. investigator.; Dalmau David investigator.; Reyes Juliana investigator.; Bruguera Andreu investigator.; Montoliu Alexandra investigator.; Muntada Esteve investigator.; Podzamczer D. investigator.; Navarro G. investigator.; Co... Journal: HIV medicine Issue: Volume 20:Issue 3(2019) Page Start: 237 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗